BCM
Bayesian Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,700
| Closed | -$34.7K | – | 671 |
|
|
2024
Q3 | $34.7K | Buy |
+10,700
| New | +$34.7K | ﹤0.01% | 632 |
|
|
2023
Q3 | – | Sell |
-10,050
| Closed | -$217K | – | 683 |
|
|
2023
Q2 | $217K | Sell |
10,050
-6,300
| -39% | -$136K | 0.02% | 624 |
|
|
2023
Q1 | $480K | Buy |
16,350
+1,650
| +11% | +$48.4K | 0.06% | 402 |
|
|
2022
Q4 | $543K | Buy |
+14,700
| New | +$543K | 0.08% | 331 |
|